InsidersTradesSigma
Browse the complete record of transactions filed by Tarriff Scott, Chief Executive Officer. Director active across 1 companies, notably Eagle Pharmaceuticals, INC.. In total, 1 reports have been recorded. The latest transaction was disclosed on 28 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration
Scott Tarriff is Chief Executive Officer of Eagle Pharmaceuticals, Inc. In this role, he oversees the company's operations and guides growth strategy. Scott is committed to strengthening the company's market position and ensuring sustainable growth while meeting customer needs. His leadership is essential for Eagle Pharmaceuticals' success.